scholarly journals Interesting Presentation of a Kounis Syndrome secondary to Amoxicillin/Clavulanate Use: Coronary Vasospasm and Simultaneous Appropriate Implantable Defibrillator Shock

2017 ◽  
Author(s):  
Ugur Canpolat
Keyword(s):  
Implantable Defibrillator ◽  
Coronary Vasospasm ◽  
Kounis Syndrome ◽  
Amoxicillin Clavulanate ◽  
Defibrillator Shock

Kounis syndrome is likely culprit of coronary vasospasm induced by capecitabine

2011 ◽  
Vol 18 (2) ◽  
pp. 316-318 ◽  
Author(s):  
Nicholas G Kounis ◽  
Grigorios G Tsigkas ◽  
George Almpanis ◽  
Andreas Mazarakis
Keyword(s):  
Coronary Vasospasm ◽  
Kounis Syndrome

Unusual Kounis Syndrome: Intraprocedure Allergic Coronary Vasospasm

2018 ◽  
Vol 27 ◽  
pp. S355
Author(s):  
A. Bhaskaran ◽  
T. Deshmukh ◽  
G. Sivagangabalan
Keyword(s):  
Coronary Vasospasm ◽  
Kounis Syndrome

Coronary vasospasm secondary to allergic reaction following food ingestion: a case of type I variant Kounis syndrome

2010 ◽  
Vol 25 (3) ◽  
pp. 263-266 ◽  
Author(s):  
Tadashi Wada ◽  
Mitsuru Abe ◽  
Nobuhito Yagi ◽  
Nobuaki Kokubu ◽  
Yoichiro Kasahara ◽  
...  
Keyword(s):  
Allergic Reaction ◽  
Coronary Vasospasm ◽  
Type I ◽  
Food Ingestion ◽  
Kounis Syndrome

Oxaliplatin-Induced Coronary Vasospasm Manifesting As Kounis Syndrome: A Case Report

2011 ◽  
Vol 29 (31) ◽  
pp. e776-e778 ◽  
Author(s):  
Pei-Hung Chang ◽  
Ming-Jui Hung ◽  
Kun-Yun Yeh ◽  
Shih-Ying Yang ◽  
Cheng-Hsu Wang
Keyword(s):  
Case Report ◽  
Coronary Vasospasm ◽  
Kounis Syndrome

scholarly journals Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak

2021 ◽  
Author(s):  
Selçuk Adabag ◽  
Patrick Zimmerman ◽  
Adam Black ◽  
Mohammad Madjid ◽  
Payam Safavi‐Naeini ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
New Orleans ◽  
York City ◽  
Implantable Defibrillator ◽  
Implantable Defibrillators ◽  
Cardioverter Defibrillator ◽  
Underlying Mechanisms ◽  
Defibrillator Shock ◽  
Related Increase

Background COVID‐19 was temporally associated with an increase in out‐of‐hospital cardiac arrests, but the underlying mechanisms are unclear. We sought to determine if patients with implantable defibrillators residing in areas with high COVID‐19 activity experienced an increase in defibrillator shocks during the COVID‐19 outbreak. Methods and Results Using the Medtronic (Mounds View, MN) Carelink database from 2019 and 2020, we retrospectively determined the incidence of implantable defibrillator shock episodes among patients residing in New York City, New Orleans, LA, and Boston, MA. A total of 14 665 patients with a Medtronic implantable defibrillator (age, 66±13 years; and 72% men) were included in the analysis. Comparing analysis time periods coinciding with the COVID‐19 outbreak in 2020 with the same periods in 2019, we observed a larger mean rate of defibrillator shock episodes per 1000 patients in New York City (17.8 versus 11.7, respectively), New Orleans (26.4 versus 13.5, respectively), and Boston (30.9 versus 20.6, respectively) during the COVID‐19 surge. Age‐ and sex‐adjusted hurdle model showed that the Poisson distribution rate of defibrillator shocks for patients with ≥1 shock was 3.11 times larger (95% CI, 1.08–8.99; P =0.036) in New York City, 3.74 times larger (95% CI, 0.88–15.89; P =0.074) in New Orleans, and 1.97 times larger (95% CI, 0.69–5.61; P =0.202) in Boston in 2020 versus 2019. However, the binomial odds of any given patient having a shock episode was not different in 2020 versus 2019. Conclusions Defibrillator shock episodes increased during the higher COVID‐19 activity in New York City, New Orleans, and Boston. These observations may provide insights into COVID‐19–related increase in cardiac arrests.

Sign in / Sign up

Export Citation Format

Share Document